US Stock MarketDetailed Quotes

AMIX Autonomix Medical

Watchlist
  • 6.000
  • -0.330-5.21%
Close Nov 26 16:00 ET
  • 5.800
  • -0.200-3.33%
Post 20:01 ET
6.91MMarket Cap-492P/E (TTM)

Autonomix Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.51%-1.6M
-180.18%-1.85M
-258.58%-6.65M
-268.87%-2.29M
-2.56M
-1.14M
-661K
-1.85M
-620K
Net income from continuing operations
53.53%-2.81M
-212.02%-2.7M
-675.18%-15.43M
-723.14%-5.41M
---3.11M
---6.04M
---865K
---1.99M
---657K
Operating gains losses
----
----
--8M
--3.03M
--178K
----
----
----
----
Depreciation and amortization
--45K
--43K
--81K
--46K
--35K
--0
--0
--0
--0
Change In working capital
1,315.69%620K
117.65%444K
-41.91%79K
-656.76%-206K
--132K
---51K
--204K
--136K
--37K
-Change in payables and accrued expense
3,892.31%493K
-106.11%-14K
338.58%557K
-627.03%-195K
--536K
---13K
--229K
--127K
--37K
-Change in other current assets
434.21%127K
1,932.00%458K
-5,411.11%-478K
---11K
---404K
---38K
---25K
--9K
--0
Cash from discontinued investing activities
Operating cash flow
-39.51%-1.6M
-180.18%-1.85M
-258.58%-6.65M
-268.87%-2.29M
---2.56M
---1.14M
---661K
---1.85M
---620K
Investing cash flow
Cash flow from continuing investing activities
0
-5K
-19K
-3K
-16K
0
0
0
0
Net PPE purchase and sale
--0
---5K
---19K
---3K
---16K
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
---5K
---19K
---3K
---16K
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
2,034.81%14.41M
1,334.07%9.68M
1.65M
350K
2.74M
675K
675K
Net issuance payments of debt
----
----
--2M
--0
--1.65M
----
----
--0
--0
Net common stock issuance
--0
--0
1,930.52%13.71M
1,509.78%10.87M
--0
--0
--2.84M
--675K
--675K
Net other financing activities
----
----
---1.3M
---1.19M
---5K
--0
---105K
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
2,034.81%14.41M
1,334.07%9.68M
--1.65M
--350K
--2.74M
--675K
--675K
Net cash flow
Beginning cash position
129.70%6.75M
895.14%8.61M
-57.68%865K
50.37%1.22M
--2.15M
--2.94M
--865K
--2.04M
--810K
Current changes in cash
-101.01%-1.6M
-189.54%-1.86M
756.74%7.74M
13,336.36%7.39M
---927K
---794K
--2.07M
---1.18M
--55K
End cash Position
140.33%5.16M
129.70%6.75M
895.14%8.61M
895.14%8.61M
--1.22M
--2.15M
--2.94M
--865K
--865K
Free cash flow
-39.51%-1.6M
-180.94%-1.86M
-259.60%-6.67M
-269.35%-2.29M
---2.57M
---1.14M
---661K
---1.85M
---620K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.51%-1.6M-180.18%-1.85M-258.58%-6.65M-268.87%-2.29M-2.56M-1.14M-661K-1.85M-620K
Net income from continuing operations 53.53%-2.81M-212.02%-2.7M-675.18%-15.43M-723.14%-5.41M---3.11M---6.04M---865K---1.99M---657K
Operating gains losses ----------8M--3.03M--178K----------------
Depreciation and amortization --45K--43K--81K--46K--35K--0--0--0--0
Change In working capital 1,315.69%620K117.65%444K-41.91%79K-656.76%-206K--132K---51K--204K--136K--37K
-Change in payables and accrued expense 3,892.31%493K-106.11%-14K338.58%557K-627.03%-195K--536K---13K--229K--127K--37K
-Change in other current assets 434.21%127K1,932.00%458K-5,411.11%-478K---11K---404K---38K---25K--9K--0
Cash from discontinued investing activities
Operating cash flow -39.51%-1.6M-180.18%-1.85M-258.58%-6.65M-268.87%-2.29M---2.56M---1.14M---661K---1.85M---620K
Investing cash flow
Cash flow from continuing investing activities 0-5K-19K-3K-16K0000
Net PPE purchase and sale --0---5K---19K---3K---16K--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0---5K---19K---3K---16K--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 002,034.81%14.41M1,334.07%9.68M1.65M350K2.74M675K675K
Net issuance payments of debt ----------2M--0--1.65M----------0--0
Net common stock issuance --0--01,930.52%13.71M1,509.78%10.87M--0--0--2.84M--675K--675K
Net other financing activities -----------1.3M---1.19M---5K--0---105K--------
Cash from discontinued financing activities
Financing cash flow --0--02,034.81%14.41M1,334.07%9.68M--1.65M--350K--2.74M--675K--675K
Net cash flow
Beginning cash position 129.70%6.75M895.14%8.61M-57.68%865K50.37%1.22M--2.15M--2.94M--865K--2.04M--810K
Current changes in cash -101.01%-1.6M-189.54%-1.86M756.74%7.74M13,336.36%7.39M---927K---794K--2.07M---1.18M--55K
End cash Position 140.33%5.16M129.70%6.75M895.14%8.61M895.14%8.61M--1.22M--2.15M--2.94M--865K--865K
Free cash flow -39.51%-1.6M-180.94%-1.86M-259.60%-6.67M-269.35%-2.29M---2.57M---1.14M---661K---1.85M---620K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data